J&J's Earnings Win Muted By Currency Impact (JNJ)

Investing

Published: July 14, 2009 6:56 am

Last Updated: July 14, 2009 1:23 pm

DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down 7.4% to $15.2 billion vs. 15.02 billion estimates. Currency was another drag on the company.

As far as the impact of currency, this was sharp. Operational results were down 1.4% and the impact of currency was negative by 6.0%. Operational growth of sales was roughly 3.9%, reflecting a negative currency impact of 11.9%.

Despite the beat on earnings, this marks a 6.7% drop in domestic sales and marks a 8% drop in international sales. Consumer product sales were down 4.5%.

J&J is also backing its annual outlook of $4.45 to $4.55 EPS for 2009. Thomson Reuters has estimates of $4.51.

Shares closed at $57.72 yesterday, and pre-market indications are up over $58.50. Its 52-week trading range is $46.25 to $72.76.

JON C. OGG
JULY 14, 2009

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.